Role of Ripk3 in Lung Injury
Author Information
Author(s): Zhao Zhaoning, Zhu Pingjun, Lou Yue, Hou Ruoyu, Sun Heqiang, Du Yingzhen, Xu Guogang
Primary Institution: Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
Hypothesis
Ripk3 influences mitochondrial fission, leading to the initiation of necroptosis in the development of ARDS.
Conclusion
Ripk3 deletion protects against LPS-induced acute lung injury by alleviating inflammation, oxidative stress, and tissue damage.
Supporting Evidence
- Ripk3 deletion improved lung tissue morphology and reduced inflammation.
- Ripk3 upregulation suppressed the AMPK pathway and activated Drp1-mediated mitochondrial fission.
- Ripk3 deletion mitigated LPS-induced necroptosis and mitochondrial damage in PMVECs.
- Ripk3 is highly involved during acute lung injury pathogenesis.
Takeaway
This study shows that a protein called Ripk3 can cause lung damage when there is an infection, but removing it helps protect the lungs.
Methodology
The study used Ripk3-deficient mice and various assays to assess lung injury, inflammation, and mitochondrial function.
Limitations
The study primarily used animal models, which may not fully replicate human conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website